Announcement on the 2022Q2 Consolidated
financial report made by Board of Directors
Date of events
2022/08/11
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/11
2.Date of the audit committee approved:2022/08/11
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):7,159,008
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):1,937,608
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):439,383
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):456,927
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):362,579
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):362,395
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):4.07
11.Total assets end of the period (thousand NTD):8,821,530
12.Total liabilities end of the period
(thousand NTD):6,675,433
13.Equity attributable to owners of parent end of the
period (thousand NTD):2,125,287
14.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
Great Tree Pharmacy Co. Ltd. published this content on 11 August 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 11 August 2022 11:45:31 UTC.
Great Tree Pharmacy Co Ltd is primarily engaged in the operation of pharmacy chain stores. It involves in the retail sale of maternal and infant supplies, national health insurance (NHI) prescription drugs, healthcare products, medical supplies and others, including home supplies and food. It operates its business in Taiwan.
GREAT TREE PHARMACY CO., LTD. 
